Incyte | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Company Directory for Incyte

Team Bitscale

13 Mar 2026 — 1 min read

Incyte

Overview

Incyte Corporation is a multinational pharmaceutical company headquartered in Wilmington, Delaware. Since its founding in 1991, the organization has focused on discovering, developing, and commercializing prescription biopharmaceutical medications targeting oncology, inflammation, and autoimmunity.

With a robust portfolio including flagship products such as JAKAFI (ruxolitinib) and OLUMIANT (baricitinib), Incyte pursues a dual business model that combines internal drug discovery with strategic collaborations. The company partners with major firms like Novartis and Eli Lilly, operates globally through strong distribution networks, and maintains a leading presence in North America, Europe, and Asia.

Basic Information

Industry	pharmaceuticals
Founded	1991
Revenue	5.1B
Headquarters	1801 Augustine Cut-Off, Wilmington, Delaware 19803, United States
Languages	English
Alexa Ranking	274454

Contact Details

Key Focus Areas & Initiatives

Immunooncology research and therapies
Drug discovery and clinical development
Targeted therapies for oncology and inflammation
Autoimmune disease treatment and management
Biotechnology innovation pipeline
Strategic pharmaceutical partnerships
Rare disease innovation
Patient-centric healthcare solutions
Biopharmaceutical manufacturing and commercialization
Clinical trials and regulatory approval
Research and development in molecular biology
Global health and commercial operations
Therapeutic pipeline management
Advancements in medical breakthroughs
Investor relations and corporate governance

Technologies Used

ADP Applicant Tracking System
ANGEL LMS
AWS SDK for JavaScript
AWS Trusted Advisor
Acquia DAM (Widen)
Amazon EC2
Amazon S3
Amazon Virtual Private Cloud (Amazon VPC)
CSC Corporate Domains
Drupal
Facebook Custom Audiences
Facebook Login (Connect)
Facebook Widget
Flask
Flow
Foxit PDF SDK
Gem
Google Font API
Google Tag Manager
GraphPad Prism
HTML Pro
Lambda Cloud
Linkedin Marketing Solutions
Lytics
Microsoft Azure Hosting
Microsoft Excel
Microsoft Office 365
Microsoft PowerPoint
Microsoft Teams
Mobile Friendly
Mode
Multilingual
Ning
OneTrust
OneTrust Tech Risk & Compliance
PeopleSoft CRM
PeopleSoft Enterprise Performance Management (EPM)
PyTorch
Python
Rapid7 InsightVM
React
Remote
SAP
SAS Enterprise Guide
Salesforce
Slack
TensorFlow
Tor
Twitter Advertising
Veeva Systems
Veeva Vault
WebSpectator
YouTube
iCIMS
reCAPTCHA

Affiliated Organizations & Regional Branches

GTM Strategy: The Complete Guide (Framework, Examples & B2B Playbook)

Most things labeled a “GTM strategy” are really a channel checklist wearing a nice slide template. They are activity plans, not a coherent answer to how the business will create, capture, and deliver value for a specific buyer in a specific market. This is written for B2B founders, product marketers,

How Scrut.io Built a Compliance-Signal GTM Machine with Bitscale

Scrut Automation simplifies continuous compliance for cloud-native companies, helping them achieve ISO 27001, SOC 2, PCI DSS, and GDPR compliance 5x faster — with real-time risk monitoring and automated evidence collection.

Clay API Limits, Authentication & Rate Limits Explained

Your enrichment workflow ran perfectly on 50 test records. Then you pointed it at 10,000 contacts and everything collapsed: 429 errors, duplicate CRM writes, and a credit balance that evaporated overnight. The Clay API usually is not the root cause. The root cause is treating authentication, rate limits, and

GTM Data Stack for US Outbound Teams

Outbound has changed. Spray-and-pray cadences that worked five years ago now burn through contact lists, damage sender reputation, and leave revenue teams short on pipeline. What separates high-performing US outbound teams in 2026 is not effort or headcount. It is the quality, governance, and architecture of the GTM Data Stack.